Adenosine A 2A receptors play a role in the pathogenesis of hepatic cirrhosis

British Journal of Pharmacology

Volumn 148, Issue 8, 2006, Pages 1144-1155

  Chan, Edwin S L ^a   Montesinos, Maria Carmen ^a   Fernandez, Patricia ^a   Desai, Avani ^a   Delano, David L ^a   Yee, Herman ^a   Reiss, Allison B ^b   Pillinger, Michael H ^a   Chen, Jiang Fan ^c   Schwarzschild, Michael A ^d   Friedman, Scott L ^e   Cronstein, Bruce N ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WINTHROP UNIVERSITY HOSPITAL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Ethanol; Hepatic fibrosis; Methotrexate; Methylxanthines; Purinergic receptor

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 8 (3 CHLOROSTYRYL)CAFFEINE; ADENOSINE; ADENOSINE A2A RECEPTOR; ALCOHOL; CAFFEINE; CARBON TETRACHLORIDE; COLLAGEN; ENPROFYLLINE; METHOTREXATE; THIOACETAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; EX VIVO STUDY; HUMAN; HUMAN CELL; INFLAMMATION; LIVER CIRRHOSIS; LUNG FIBROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; STELLATE CELL; TISSUE REPAIR;

ADENOSINE; ADENOSINE A2 RECEPTOR AGONISTS; ANIMALS; BLOTTING, WESTERN; CAFFEINE; CARBON TETRACHLORIDE; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ETHANOL; HEPATOCYTES; HUMANS; LIVER CIRRHOSIS; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METHOTREXATE; MICE; MICE, INBRED C57BL; RATS; RECEPTOR, ADENOSINE A2A; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THIOACETAMIDE; TRIAZINES; TRIAZOLES;

EID: 33747087250     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706812     Document Type: Article

References (65)

1. AGUADO, J.M., PONS, F., CASAFONT, F., SAN MIGUEL, G. & VALLE, R. (1990). Tuberculous peritonitis: a study comparing cirrhotic and noncirrhotic patients. J. Clin. Gastroenterol., 12, 550-554.
2. ANDERSSON, S.E., JOHANSSON, L.H., LEXMULLER, K. & EKSTROM, G.M. (2000). Anti-arthritic effect of methotrexate: is it really mediated by adenosine? Eur. J. Pharm. Sci., 9, 333-343.
3. BLACKBURN, M.R., LEE, C.G., YOUNG, H.W., ZHU, Z., CHUNN, J.L., KANG, M.J., BANERJEE, S.K. & ELIAS, J.A. (2003). Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway. J. Clin. Invest., 112, 332-344.
4. BSHESH, K., ZHAO, B., SPIGHT, D., BIAGGIONI, I., FEOKISTOV, I., DENENBERG, A., WONG, H.R. & SHANLEY, T.P. (2002). The A2A receptor mediates an endogenous regulatory pathway of cytokine expression in THP-1 cells. J. Leukoc. Biol., 72, 1027-1036.
5. BURGESS, L.J., SWANEPOEL, C.G. & TALJAARD, J.J. (2001). The use of adenosine deaminase as a diagnostic tool for peritoneal tuberculosis. Tuberculosis (Edinb), 81, 243-248.
6. CHAN, E.S. & CRONSTEIN, B.N. (2002). Molecular action of methotrexate in inflammatory diseases. Arthritis Res., 4, 266-273.
7. CHEN, J.F., HUANG, Z., MA, J., ZHU, J., MORATALLA, R., STANDAERT, D., MOSKOWITZ, M.A., FINK, J.S. & SCHWARZSCHILD, M.A. (1999). A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J. Neurosci., 19, 9192-9200.
8. CORRAO, G., LEPORE, A.R., TORCHIO, P., VALENTI, M., GALATOLA, G., D'AMICIS, A., ARICO, S. & DI ORIO, F. (1994). The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case-control study. Provincial Group for the Study of Chronic Liver Disease. Eur. J. Epidemiol., 10, 657-664.
9. CORRAO, G., ZAMBON, A., BAGNARDI, V., D'AMICIS, A. & KLATSKY, A. (2001). Coffee, caffeine, and the risk of liver cirrhosis. Ann. Epidemiol., 11, 458-465.
10. CRONSTEIN, B.N., EBERLE, M.A., GRUBER, H.E. & LEVIN, R.I. (1991). Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc. Natl. Acad. Sci. U.S.A., 88, 2441-2445.
11. CRONSTEIN, B.N., KRAMER, S.B., WEISSMANN, G. & HIRSCHHORN, R. (1983a). Adenosine: a physiological modulator of superoxide anion generation by human neutrophils. J. Exp. Med., 158, 1160-1177.
12. CRONSTEIN, B.N., KRAMER, S.B., WEISSMANN, G. & HIRSCHHORN, R. (1983b). A new physiological function for adenosine: regulation of superoxide anion production. Trans. Assoc. Am. Physicians, 96, 384-391.
13. CRONSTEIN, B.N., LEVIN, R.I., BELANOFF, J., WEISSMANN, G. & HIRSCHHORN, R. (1986). Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. J. Clin. Invest., 78, 760-770.
14. CRONSTEIN, B.N., MONTESINOS, M.C. & WEISSMANN, G. (1999). Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB. Proc. Natl. Acad. Sci. U.S.A., 96, 6377-6381.
15. CRONSTEIN, B.N., NAIME, D. & OSTAD, E. (1993). The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J. Clin. Invest., 92, 2675-2682.
16. CRONSTEIN, B.N., ROSENSTEIN, E.D., KRAMER, S.B., WEISSMANN, G. & HIRSCHHORN, R. (1985). Adenosine; a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils. J. Immunol., 135, 1366-1371.
17. DE LA MONTE, S.M., HUTCHINS, G.M. & MOORE, G.W. (1984). Risk factors for development of lethal sequelae after hepatitis B virus infection in humans. Am. J. Med., 77, 482-488.
18. DESAI, A., VICTOR-VEGA, C., GADANGI, S., MONTESINOS, M.C., CHU, C.C. & CRONSTEIN, B.N. (2005). Adenosine A2A receptor stimulation increases angiogenesis by down-regulating production of the antiangiogenic matrix protein thrombospondin 1. Mol. Pharmacol., 67, 1406-1413.
19. DUNWIDDIE, T.V. & MASINO, S.A. (2001). The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci., 24, 31-55.
20. EL YACOUBI, M., LEDENT, C., PARMENTIER, M., COSTENTIN, J. & VAUGEOIS, J.M. (2003). Caffeine reduces hypnotic effects of alcohol through adenosine A2A receptor blockade. Neuropharmacology, 45, 977-985.
21. EL YACOUBI, M., LEDENT, C., PARMENTIER, M., DAOUST, M., COSTENTIN, J. & VAUGEOIS, J. (2001). Absence of the adenosine A(2A) receptor or its chronic blockade decrease ethanol withdrawal-induced seizures in mice. Neuropharmacology, 40, 424-432.
22. FERNANDEZ, E., RODRIGO, L., RIESTRA, S., CARCIA, S., GUTIERREZ, F. & OCIO, G. (2000). Adenosine deaminase isoenzymes and neopterin in liver cirrhosis. J. Clin. Gastroenterol., 30, 181-186.
23. FRENCH, S.W. (2000). Mechanisms of alcoholic liver injury. Can. J. Gastroenterol., 14, 327-332.
24. FRIEDMAN, S.L. (2000). Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem., 275, 2247-2250.
25. GALLUS, S., TAVANI, A., NEGRI, E. & LA VECCHIA, C. (2002). Does coffee protect against liver cirrhosis? Ann. Epidemiol., 12, 202-205.
26. 2+ and cAMP. Eur. J. Pharmacol., 437, 105-111.
27. HERNANDEZ-MUNOZ, R., DIAZ-MUNOZ, M. & CHAGOYA DE SANCHEZ, V. (1994). Possible role of cell redox state on collagen metabolism in carbon tetrachloride-induced cirrhosis as evidenced by adenosine administration to rats. Biochim. Biophys. Acta, 1200, 93-99.
28. HERNANDEZ-MUNOZ, R., DIAZ-MUNOZ, M., SUAREZ, J. & CHAGOYA DE SANCHEZ, V. (1990). Adenosine partially prevents cirrhosis induced by carbon tetrachloride in rats. Hepatology, 12, 242-248.
29. HERNANDEZ-MUNOZ, R., DIAZ-MUNOZ, M., SUAREZ-CUENCA, J.A., TREJO-SOLIS, C., LOPEZ, V., SANCHEZ-SEVILLA, L., YANEZ, L. & DE SANCHEZ, V.C. (2001). Adenosine reverses a preestablished CCl4-induced micronodular cirrhosis through enhancing collagenolytic activity and stimulating hepatocyte cell proliferation in rats. Hepatology, 34, 677-687.
30. ISHAK, K., BAPTISTA, A., BIANCHI, L., CALLEA, F., DE GROOTE, J., GUDAT, F., DENK, H., DESMET, V., KORB, G., MACSWEEN, R.N.M., PHILLIPS, M.J., PORTMANN, B.G., POULSEN, H., SCHEUER, P.J., SCHMID, M. & THALER, H. (1995). Histological grading and staging of chronic hepatitis. J. Hepatol., 22, 696-699.
31. ITOH, A., NODA, Y., MAMIYA, T., HASEGAWA, T. & NABESHIMA, T. (1998). A therapeutic strategy to prevent morphine dependence and tolerance by coadministration of cAMP-related reagents with morphine. Methods Find. Exp. Clin. Pharmacol., 20, 619-625.
32. JAMES, J., BOSCH, K.S., ARONSON, D.C. & HOUTKOOPER, J.M. (1990). Sirius red histophotometry and spectrophotometry of sections in the assessment of the collagen content of liver tissue and its application in growing rat liver. Liver, 10, 1-5.
33. KAPLAN, G.B., BHARMAL, N.H., LEITE-MORRIS, K.A. & ADAMS, W.R. (1999). Role of adenosine A1 and A2A receptors in the alcohol withdrawal syndrome. Alcohol, 19, 157-162.
34. KHOA, N.D., MONTESINOS, M.C., REISS, A.B., DELANO, D., AWADALLAH, N. & CRONSTEIN, B.N. (2001). Inflammatory cytokines regulate function and expression of adenosine A(2A) receptors in human monocytic THP-1 cells. J. Immunol., 167, 4026-4032.
35. KLATSKY, A.L., ARMSTRONG, M.A. & FRIEDMAN, G.D. (1993). Coffee, tea, and mortality. Ann. Epidemiol., 3, 375-381.
36. KNODELL, R.G., ISHAK, K.G., BLACK, W.C., CHEN, T.S., CRAIG, R., KAPLOWITZ, N., KIERNAN, T.W. & WOLLMAN, J. (1981). Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology, 1, 431-435.
37. LEE, H.T., OTA-SETLIK, A., XU, H., D'AGATI, V.D., JACOBSON, M.A. & EMALA, C.W. (2002). A3 adenosine receptor knock-out mice are protected against ischemic- and myoglobinuric-induced renal failure. Am. J. Physiol. Renal Physiol., 284, F267-F273.
38. LI, D. & FRIEDMAN, S.L. (1999). Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy. J. Gastroenterol. Hepatol., 14, 618-633.
39. LINDEN, J. (2001). Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu. Rev. Pharmacol. Toxicol., 41, 775-787.
40. MAUVIEL, A., REDINI, F., HARTMANN, D.J., PUJOL, J.P. & EVANS, C.H. (1991). Modulation of human dermal fibroblast extracellular matrix metabolism by the lymphokine leukoregulin. J. Cell Biol., 113, 1455-1462.
41. MIYAMOTO, K. & FRENCH, S.W. (1988). Hepatic adenosine in rats fed ethanol: effect of acute hyperoxia or hypoxia. Alcohol Clin. Exp. Res., 12, 512-515.
42. MONTESINOS, M.C., DESAI, A., CHEN, J.F., YEE, H., SCHWARZSCHILD, M.A., FINK, J.S. & CRONSTEIN, B.N. (2002). Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A(2A) receptors. Am. J. Pathol., 160, 2009-2018.
43. MONTESINOS, M.C., GADANGI, P., LONGAKER, M., SUNG, J., LEVINE, J., NILSEN, D., REIBMAN, J., LI, M., JIANG, C.K., HIRSCHHORN, R., RECHT, P.A., OSTAD, E., LEVIN, R.I. & CRONSTEIN, B.N. (1997). Wound healing is accelerated by agonists of adenosine A2 (G alpha s-linked) receptors. J. Exp. Med., 186, 1615-1620.
44. MORABITO, L., MONTESINOS, M.C., SCHREIBMAN, D.M., BALTER, L., THOMPSON, L.F., RESTA, R., CARLIN, G., HUIE, M.A. & CRONSTEIN, B.N. (1998). Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5′-nucleotidase-mediated conversion of adenine nucleotides. J. Clin. Invest., 101, 295-300.
45. MOSER, G.H., SCHRADER, J. & DEUSSEN, A. (1989). Turnover of adenosine in plasma of human and dog blood. Am. J. Physiol., 256, C799-C806.
46. NAASSILA, M., LEDENT, C. & DAOUST, M. (2002). Low ethanol sensitivity and increased ethanol consumption in mice lacking adenosine A2A receptors. J. Neurosci., 22, 10487-10493.
47. NAGY, L.E., DIAMOND, I., CASSO, D.J., FRANKLIN, C. & GORDON, A.S. (1990). Ethanol increases extracellular adenosine by inhibiting adenosine uptake via the nucleoside transporter. J. Biol. Chem., 265, 1946-1951.
48. NGUYEN, D.K., MONTESINOS, M.C., WILLIAMS, A.J., KELLY, M. & CRONSTEIN, B.N. (2003). Th1 cytokines regulate adenosine receptors and their downstream signaling elements in human microvascular endothelial cells. J. Immunol., 171, 3991-3998.
49. OHTA, A. & SITKOVSKY, M. (2001). Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature, 414, 916-920.
50. PUIG, J.G. & FOX, I.H. (1984). Ethanol-induced activation of adenine nucleotide turnover. Evidence for a role of acetate. J. Clin. Invest., 74, 936-941.
51. QUIROZ, S.C., BUCIO, L., SOUZA, V., HERNANDEZ, E., GONZALEZ, E., GOMEZ-QUIROZ, L., KERSHENOBICH, D., VARGASVORACKOVA, F. & GUTIERREZ-RUIZ, M.C. (2001). Effect of endotoxin pretreatment on hepatic stellate cell response to ethanol and acetaldehyde. J. Gastroenterol. Hepatol., 16, 1267-1273.
52. RALEVIC, V. & BURNSTOCK, G. (1998). Receptors for purines and pyrimidines. Pharmacol. Rev., 50, 413-492.
53. REEVES, H.L. & FRIEDMAN, S.L. (2002). Activation of hepatic stellate cells - a key issue in liver fibrosis. Front. Biosci., 7, d808-d826.
54. REINEHR, R., FISCHER, R. & HAUSSINGER, D. (2002). Regulation of endothelin-A receptor sensitivity by cyclic adenosine monophosphate in rat hepatic stellate cells. Hepatology, 36, 861-873.
55. REINSTEIN, L.J., LICHTMAN, S.N., CURRIN, R.T., WANG, J., THURMAN, R.G. & LEMASTERS, J.J. (1994). Suppression of lipopolysaccharide-stimulated release of tumor necrosis factor by adenosine: evidence for A2 receptors on rat Kupffer cells. Hepatology, 19, 1445-1452.
56. RUHL, C.E. & EVERHART, J.E. (2005). Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology, 129, 1928-1936.
57. SHARP, D.S., EVERHART, J.E. & BENOWITZ, N.L. (1999). Coffee, alcohol, and the liver. Ann. Epidemiol., 9, 391-393.
58. STEGEMANN, H. & STALDER, K. (1967). Determination of hydroxyproline. Clin. Chim. Acta, 18, 267-273.
59. SUN, C.X., YOUNG, H.W., MOLINA, J.G., VOLMER, J.B., SCHNERMANN, J. & BLACKBURN, M.R. (2005). A protective role for the A1 adenosine receptor in adenosine-dependent pulmonary injury. J. Clin. Invest., 115, 35-43.
60. TAIMR, P., HIGUCHI, H., KOCOVA, E., RIPPE, R.A., FRIEDMAN, S. & GORES, G.J. (2003). Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis. Hepatology, 37, 87-95.
61. TOBIAS, H. & AUERBACH, R. (1973). Hepatotoxicity of long-term methotrexate therapy for psoriasis. Arch. Intern. Med., 132, 391-396.
62. VICTOR-VEGA, C., DESAI, A., MONTESINOS, M.C. & CRONSTEIN, B.N. (2002). Adenosine A2A receptor agonists promote more rapid wound healing than recombinant human platelet-derived growth factor (Becaplermin gel). Inflammation, 26, 19-24.
63. VOGEL, S., PIANTEDOSI, R., FRANK, J., LALAZAR, A., ROCKEY, D.C., FRIEDMAN, S.L. & BLANER, W.S. (2000). An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J. Lipid Res., 41, 882-893.
64. WONG, F.W., CHAN, W.Y. & LEE, S.S. (1998). Resistance to carbon tetrachloride-induced hepatotoxicity in mice which lack CYP2E1 expression. Toxicol. Appl. Pharmacol., 153, 109-118.
65. XU, L., HUI, A.Y., ALBANIS, E., ARTHUR, M.J., O'BYRNE, S.M., BLANER, W.S., MUKHERJEE, P., FRIEDMAN, S.L. & ENG, F.J. (2005). Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut, 54, 142-151.